AI reads CT scans to spot stomach cancer stage with precision
NCT ID NCT07250347
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing an artificial intelligence system that analyzes routine contrast-enhanced CT scans to detect stomach cancer and determine its stage (how far it has spread). The goal is to help doctors decide the best treatment, such as whether surgery is needed and how much tissue to remove. The trial will involve 8,000 patients across multiple hospitals and compare the AI's accuracy to that of radiologists.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- artificial intelligence system analyzing contrast-enhanced CT scans
- What this could lead to
- If successful, this AI tool could help doctors more accurately stage gastric cancer from routine CT scans, leading to better treatment decisions and fewer unnecessary surgeries.
- What could go wrong
- This is an early-stage study testing the AI's performance against standard practice. The AI may not work as well in all hospitals or for all patients, and it is not yet proven to improve patient outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC CANCER PATIENTS UNDERGOING GASTRECTOMY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The First Affiliated Hospital of Nanjing Medical University
RECRUITINGNanjing, Jiangsu, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.